Compounds > erythromycin

Page last updated: 2024-08-21

erythromycin and bromhexine

erythromycin has been researched along with bromhexine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Bergogne-Bérézin, E; Berthelot, G; Dournovo, P; Kafé, HP	1
Brouwers, J; Davies, BI; Maesen, FP; Rubingh, G	1
Bergogne-Berezin, E; Dournovo, P; Pierre, J	1
Wiemeyer, JC	1

Trials

3 trial(s) available for erythromycin and bromhexine

Article	Year
Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions. International journal of clinical pharmacology research, 1985, Volume: 5, Issue:5 Topics: Bromhexine; Bronchi; Bronchiectasis; Bronchitis; Double-Blind Method; Drug Interactions; Erythromycin; Humans; Random Allocation	1985
Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness. European journal of respiratory diseases, 1982, Volume: 63, Issue:4 Topics: Bromhexine; Bronchitis; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Pneumococcal Infections; Sputum	1982
[Effect of a secretolytic agent (bromhexine) on the penetration of erythromycin into bronchial secretions]. Fortschritte der Medizin, 1982, Jun-24, Volume: 100, Issue:24 Topics: Bromhexine; Clinical Trials as Topic; Double-Blind Method; Erythromycin; Humans; Mucus; Respiratory Tract Infections	1982

Other Studies

5 other study(ies) available for erythromycin and bromhexine

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Influence of ambroxol on the bronchopulmonary level of antibiotics. Arzneimittel-Forschung, 1981, Volume: 31, Issue:6 Topics: Ambroxol; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Bromhexine; Drug Interactions; Erythromycin; Female; Lung; Male; Rats	1981